Los medicamentos GLP-1 aprobados por la FDA, como semaglutida (Ozempic, Wegovy) y liraglutida (Victoza, Saxenda), producen aumentos farmacolgicos sostenidos en la actividad del receptor de GLP-1, resultando en reducciones de hemoglobina A1c de 1.0-1.5% y prdida de peso de 10-15% o ms
The dual mechanism of tirzepatide, targeting GLP-1 and GIP receptors, effectively manages both blood sugar levels and appetite, making it innovative
Your body runs on fuel
Research indicates that BPC-157 facilitates nerve regeneration, improves mobility, and fosters neuroprotective effects in SCI models
For Rapid Skin Brightening & Detoxification : Injections provide faster outcomes but necessitate medical supervision and a higher financial commitment
Hydroxo B12 with Folinic Acid contains potent methyl-free B12 and folate to support healthy homocysteine levels, energy, and cognition